Virax Biolabs
VRAX
VRAX
6 hedge funds and large institutions have $183K invested in Virax Biolabs in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SSA
1
Schonfeld Strategic Advisors
New York
|
$115K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$38K |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$28K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$2K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $115K | 36,600 | +36,600 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $38K | 12,196 | +12,196 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| $28K | 8,928 | +8,928 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2K | 649 | +649 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1 | +1 | – |
|
|
RAM
7
Riggs Asset Management
Dallas,
Pennsylvania
| $0 | 4 | +4 | – |
|